Proceedings: Recurrent pheochromocytoma.
D000008:Abdominal Neoplasms / Q000601:surgery*; D000293:Adolescent; D000310:Adrenal Gland Neoplasms / Q000601:surgery*; D000328:Adult; D002648:Child; D004837:Epinephrine / Q000378:metabolism; D005260:Female; D006729:Hormones, Ectopic / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology; D008113:Liver Neoplasms / Q000601:surgery; D008175:Lung Neoplasms / Q000601:surgery; D008198:Lymph Nodes; D008207:Lymphatic Metastasis / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000601:surgery; D009364:Neoplasm Recurrence, Local / Q000601:surgery*; D009378:Neoplasms, Multiple Primary / Q000601:surgery; D009638:Norepinephrine / Q000378:metabolism; D010293:Pargyline / Q000009:adverse effects / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000188:drug therapy / Q000601:surgery*; D011183:Postoperative Complications; D011247:Pregnancy; D011248:Pregnancy Complications / Q000601:surgery; D011433:Propranolol / Q000627:therapeutic use; D013899:Thoracic Neoplasms / Q000601:surgery*; D001749:Urinary Bladder Neoplasms / Q000601:surgery*
D006729:Hormones, Ectopic; D010643:Phenoxybenzamine; D010293:Pargyline; D011433:Propranolol; D009638:Norepinephrine; D004837:Epinephrine